Italy · AIFA medicine catalogue
XOFLUZA
A source-listed package record. Different packs may share the same medicine name.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 049329055
- Form
- Granulato per sospensione orale
- Composition / generic term
- BALOXAVIR MARBOXIL
- Company as listed by source
- ROCHE REGISTRATION GMBH
- Source status
- Autorizzata
- Supply classification
- Medicinali soggetti a prescrizione medica
Source-listed ingredients
- BALOXAVIR MARBOXIL — 2 milligram(s)/millilitre
These values do not establish equivalence or a dose recommendation.
Packages
- 2 mg / ml - Granulato per sospensione orale - Uso orale - Flacone (vetro) 40 mg - 1 flacone + 1 misurino + 1 adattatore per il flacone + 1 siringa per uso orale da 3 ml + 1 siringa per uso orale da 10 ml
Source and coverage
Open AIFA medicine catalogue →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Italy records →